-
Loading metrics
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors
-
Jens Panse ,
Roles Formal analysis, Investigation, Visualization, Writing – review & editing
* E-mail: jpanse@ukaachen.de
Affiliations Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany, Center for Integrated Oncology (CIO), Dusseldorf (ABCD), Aachen, Bonn, Cologne, Germany
⨯ - Nicolas Daguindau,
- Sonia Okuyama,
- Régis Peffault de Latour,
- Philippe Schafhausen,
- Nicole Straetmans,
- Mohammed Al-Adhami,
- Emmelie Persson,
-
Raymond Siu Ming Wong
Roles Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
⨯
https://orcid.org/0000-0001-6316-3112
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors
- Jens Panse,
- Nicolas Daguindau,
- Sonia Okuyama,
- Régis Peffault de Latour,
- Philippe Schafhausen,
- Nicole Straetmans,
- Mohammed Al-Adhami,
- Emmelie Persson,
- Raymond Siu Ming Wong
x
- Published: July 29, 2024
- https://doi.org/10.1371/journal.pone.0306407